GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) » Definitions » Change In Receivables

Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Tonghua Dongbao Pharmaceutical Co Change In Receivables?

Tonghua Dongbao Pharmaceutical Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Tonghua Dongbao Pharmaceutical Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Tonghua Dongbao Pharmaceutical Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥-431 Mil. It means Tonghua Dongbao Pharmaceutical Co's Accounts Receivable increased by ¥431 Mil from Dec. 2022 to Dec. 2023 .

Tonghua Dongbao Pharmaceutical Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥830 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Tonghua Dongbao Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 128.07.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Tonghua Dongbao Pharmaceutical Co's liquidation value for the three months ended in Mar. 2024 was ¥1,679 Mil.


Tonghua Dongbao Pharmaceutical Co Change In Receivables Historical Data

The historical data trend for Tonghua Dongbao Pharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tonghua Dongbao Pharmaceutical Co Change In Receivables Chart

Tonghua Dongbao Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -43.14 2.33 -88.27 140.57 -430.93

Tonghua Dongbao Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Tonghua Dongbao Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tonghua Dongbao Pharmaceutical Co  (SHSE:600867) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Tonghua Dongbao Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=830.03/591.386*91
=128.07

2. In Ben Graham's calculation of liquidation value, Tonghua Dongbao Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Tonghua Dongbao Pharmaceutical Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=1173.276-467.009+0.75 * 830.03+0.5 * 700.315
=1,679

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tonghua Dongbao Pharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Tonghua Dongbao Pharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Business Description

Traded in Other Exchanges
N/A
Address
Dongbao Village, Jilin Province, Tonghua, CHN, 134123
Tonghua Dongbao Pharmaceutical Co Ltd is a China-based firm. Its engaged in the production and distribution of pharmaceutical products. Its products include human insulin injection, Heart and brain capsule, Vitamin e soft capsule, and Oral detoxification products.
Executives
Cheng Jian Qiu Supervisors
Chang Xiao Hui Director
Li Cong Director
Li Feng Qin Director
Chen Hong senior management
Leng Chun Sheng Director
Li Yi Kui Director
Wang Dian Duo Supervisors
Wang Jun Ye Director
Han Jie Director

Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Headlines

No Headlines